Catalyst Wire Dossier Catalyst Wire Dossier

Aetoxysklerol Foam (0.2%)

polidocanol
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aetoxysklerol Foam (0.2%), covering 2025-07-18 to 2025-07-18. Get the full timeline:

Most recent: Clinical Trial Update: CLaCS Using 0.2% Aetoxysklerol Foam and 70% Glucose for the Treatment of Lower Limb Telangiectasias [Phase 2]

See pricing